These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16381664

  • 1. Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments.
    Ballent M, Lifschitz A, Virkel G, Sallovitz J, Lanusse C.
    Drug Metab Dispos; 2006 Mar; 34(3):457-63. PubMed ID: 16381664
    [Abstract] [Full Text] [Related]

  • 2. Sex-related differences in the gastrointestinal disposition of ivermectin in the rat: P-glycoprotein involvement and itraconazole modulation.
    Lifschitz A, Ballent M, Virkel G, Sallovitz J, Lanusse C.
    J Pharm Pharmacol; 2006 Aug; 58(8):1055-62. PubMed ID: 16872551
    [Abstract] [Full Text] [Related]

  • 3. Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazole-mediated changes on gastrointestinal disposition.
    Ballent M, Lifschitz A, Virkel G, Sallovitz J, Lanusse C.
    J Vet Pharmacol Ther; 2007 Jun; 30(3):242-8. PubMed ID: 17472656
    [Abstract] [Full Text] [Related]

  • 4. Loperamide modifies the tissue disposition kinetics of ivermectin in rats.
    Lifschitz AL, Virkel GL, Sallovitz JM, Pis A, Imperiale FA, Lanusse CE.
    J Pharm Pharmacol; 2004 Jan; 56(1):61-7. PubMed ID: 14980002
    [Abstract] [Full Text] [Related]

  • 5. Combined use of ivermectin and triclabendazole in sheep: in vitro and in vivo characterisation of their pharmacological interaction.
    Lifschitz A, Virkel G, Ballent M, Sallovitz J, Lanusse C.
    Vet J; 2009 Nov; 182(2):261-8. PubMed ID: 18640064
    [Abstract] [Full Text] [Related]

  • 6. Gender-related differences on P-glycoprotein-mediated drug intestinal transport in rats.
    Mariana B, Adrián L, Guillermo V, Juan S, Laura M, Carlos L.
    J Pharm Pharmacol; 2011 May; 63(5):619-26. PubMed ID: 21492163
    [Abstract] [Full Text] [Related]

  • 7. Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal disposition.
    Ballent M, Lifschitz A, Virkel G, Mate L, Lanusse C.
    J Vet Pharmacol Ther; 2010 Jun 01; 33(3):252-9. PubMed ID: 20557442
    [Abstract] [Full Text] [Related]

  • 8. P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus.
    Bartley DJ, McAllister H, Bartley Y, Dupuy J, Ménez C, Alvinerie M, Jackson F, Lespine A.
    Parasitology; 2009 Aug 01; 136(9):1081-8. PubMed ID: 19549355
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs.
    Alvarez L, Lifschitz A, Entrocasso C, Manazza J, Mottier L, Borda B, Virkel G, Lanusse C.
    J Vet Pharmacol Ther; 2008 Jun 01; 31(3):230-9. PubMed ID: 18471144
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of ivermectin against Strongyloides stercoralis infection in jirds (Meriones unguiculatus).
    Sithithaworn P, Fujimaki Y, Mitsui Y, Prasanthong R, Yutanawiboonchai W, Aoki Y.
    Exp Parasitol; 1998 Jun 01; 89(2):205-12. PubMed ID: 9635444
    [Abstract] [Full Text] [Related]

  • 11. Ivermectin (3.15%) long-acting formulations in cattle: absorption pattern and pharmacokinetic considerations.
    Lifschitz A, Virkel G, Ballent M, Sallovitz J, Imperiale F, Pis A, Lanusse C.
    Vet Parasitol; 2007 Jul 20; 147(3-4):303-10. PubMed ID: 17524559
    [Abstract] [Full Text] [Related]

  • 12. Role of P-glycoprotein in the disposition of macrocyclic lactones: A comparison between ivermectin, eprinomectin, and moxidectin in mice.
    Kiki-Mvouaka S, Ménez C, Borin C, Lyazrhi F, Foucaud-Vignault M, Dupuy J, Collet X, Alvinerie M, Lespine A.
    Drug Metab Dispos; 2010 Apr 20; 38(4):573-80. PubMed ID: 20089736
    [Abstract] [Full Text] [Related]

  • 13. Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein.
    Kwei GY, Alvaro RF, Chen Q, Jenkins HJ, Hop CE, Keohane CA, Ly VT, Strauss JR, Wang RW, Wang Z, Pippert TR, Umbenhauer DR.
    Drug Metab Dispos; 1999 May 20; 27(5):581-7. PubMed ID: 10220486
    [Abstract] [Full Text] [Related]

  • 14. Combined subcutaneous administration of ivermectin and nitroxynil in sheep: age/body weight related changes to the kinetic disposition of both compounds.
    Moreno L, Ceballos L, Lifschitz A, Bistoletti M, Alvarez L, Lanusse C.
    Res Vet Sci; 2010 Apr 20; 88(2):315-20. PubMed ID: 19892381
    [Abstract] [Full Text] [Related]

  • 15. The metabolism of midazolam and comparison with other CYP enzyme substrates during intestinal absorption: in vitro studies with rat everted gut sacs.
    Arellano C, Philibert C, Vachoux C, Woodley J, Houin G.
    J Pharm Pharm Sci; 2007 Apr 20; 10(1):26-36. PubMed ID: 17498391
    [Abstract] [Full Text] [Related]

  • 16. Modulation of the p-glycoproein-mediated intestinal secretion of glibenclamide: in vitro and in vivo assessments.
    Srirangam P, Vidya SJ.
    J Young Pharm; 2010 Oct 20; 2(4):379-83. PubMed ID: 21264098
    [Abstract] [Full Text] [Related]

  • 17. Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.
    Shirasaka Y, Masaoka Y, Kataoka M, Sakuma S, Yamashita S.
    Drug Metab Dispos; 2008 May 20; 36(5):916-22. PubMed ID: 18276834
    [Abstract] [Full Text] [Related]

  • 18. Breed-related plasma disposition of ivermectin following subcutaneous administration in Kilis and Damascus goats.
    Gokbulut C, Bilgili A, Hanedan B, Aksit D, Aksoy AM, Turgut C.
    Res Vet Sci; 2009 Dec 20; 87(3):445-8. PubMed ID: 19410269
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effect of docosahexaenoic acid (DHA) on the intestinal metabolism of midazolam: in vitro and in vivo studies in rats.
    Hirunpanich V, Murakoso K, Sato H.
    Int J Pharm; 2008 Mar 03; 351(1-2):133-43. PubMed ID: 18082981
    [Abstract] [Full Text] [Related]

  • 20. Effect of parasitism on the pharmacokinetic disposition of ivermectin in lambs.
    Pérez R, Palma C, Cabezas I, Araneda M, Rubilar L, Alvinerie M.
    J Vet Med A Physiol Pathol Clin Med; 2006 Feb 03; 53(1):43-8. PubMed ID: 16411909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.